About Us CHU Rouen among the first centers in Europe to adopt Valvosoft® technology following its CE marking Jul 9, 2026 HeleneCardiawave 0
Press Release Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Jun 16, 2026 HeleneCardiawave 0
Scientific PublicationsCardiawave’s First-in-Human clinical studies results published in The Lancet! Nov 17, 2023 READ MORE
Press ReleaseCardiawave announces the publication in The Lancet of First-In-Human clinical studies results Nov 15, 2023 READ MORE
About Us CHU Rouen among the first centers in Europe to adopt Valvosoft® technology following its CE marking Jul 9, 2026 HeleneCardiawave 0
Press Release Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Jun 16, 2026 HeleneCardiawave 0
